Raynaud's syndrome is a condition characterized by episodic vasospasm of the small arteries, typically in the fingers and toes, in response to cold or emotional stress. It leads to reversible skin color changes (pallor, cyanosis, erythema) and sensory symptoms such as pain or tingling.
Classification
- Primary Raynaud's (Raynaud's disease):
- Idiopathic, more common (>80% of cases)
- No underlying disease
- Typically mild and symmetrical
- Usually begins in women <30 years
- No digital ulcers or tissue necrosis
- Secondary Raynaud's (Raynaud’s phenomenon):
- Associated with underlying conditions such as:
- Systemic sclerosis (most common)
- SLE, Sjögren’s syndrome, dermatomyositis, RA
- Atherosclerosis, thoracic outlet syndrome
- Drugs (e.g., beta-blockers, ergotamines, chemotherapeutics)
- Occupational (vibration injury)
- Often severe, may be asymmetric, can lead to ulcers/gangrene
- Associated with underlying conditions such as:
Pathophysiology
- Vasospasm → ↓ blood flow → ischemia (white phase)
- Accumulated deoxygenated blood → cyanosis (blue phase)
- Reperfusion → reactive hyperemia (red phase)
Mechanisms Involved:
- Hyperactivation of alpha-2 adrenergic receptors
- ↑ Platelet α2-receptors in affected individuals
- Estrogen, serotonin, endothelin-1, and nitric oxide may play roles
- Genetic predisposition: familial clustering reported
- Sympathetic overactivity or vascular dysfunction likely contributes
Epidemiology
- More common in females (especially of childbearing age)
- Often resolves after menopause
- Occurs in up to 5-10% of the population
Clinical Features
Triggering factors:
- Cold exposure
- Emotional stress
- Vibrations
Phases:
- Pallor (white): due to vasospasm and ischemia
- Cyanosis (blue): due to desaturation of blood
- Erythema (red): due to reactive hyperemia
Other features:
- Burning, tingling, numbness
- Symmetrical involvement in primary
- Typically spares the thumb
- Most commonly affects the index, middle, and ring fingers
- Attacks last minutes to hours
Diagnosis
- Clinical diagnosis based on symptoms and history
- Rule out acrocyanosis (persistent cyanosis without ischemia or pain)
Workup for Secondary Raynaud’s:
- ANA, ESR, RF
- Anti-centromere antibody (CREST)
- Anti-Scl-70 (anti-topoisomerase I) (systemic sclerosis)
- Nailfold capillaroscopy
- Digital artery Doppler ultrasound
Management
General Measures:
- Avoid cold exposure
- Wear warm gloves
- Smoking cessation
- Stress management
Pharmacologic Therapy:
- Calcium Channel Blockers (CCBs) : First-line
- Nifedipine , Amlodipine, Felodipine
- Alpha-blockers : e.g., Prazosin
- Topical nitroglycerin (for digital ulcers)
- PDE inhibitors : Sildenafil
- Pentoxifylline : improves microcirculation
Advanced/Severe Disease (usually secondary):
- Iloprost (IV prostaglandin analog) – for critical ischemia
- Bosentan (Endothelin receptor antagonist) – for digital ulcers in scleroderma
- Surgical sympathectomy : Reserved for refractory cases
- Analgesics and antibiotics for ulcer management
Contraindicated Drugs:
- Beta-blockers (except cardioselective ones like nebivolol)
- Clonidine
- Ergot derivatives
- Sudafed and stimulants
Key Differentiating Points:
| Feature | Primary Raynaud's | Secondary Raynaud's |
|---|---|---|
| Age | <30 years | >30 years |
| Severity | Mild, symmetric | Severe, may be asymmetric |
| Ulcers/Gangrene | No | Common |
| Associated disease | None | Yes (e.g., SLE, scleroderma) |
| Nailfold capillaries | Normal | Abnormal (e.g., dilated, dropout) |
High-Yield Notes:
- Raynaud's can precede systemic sclerosis by years – monitor closely.
- Triphasic color change is classic but not always present.
- Patients with anti-centromere antibodies are at risk of CREST syndrome.
- Avoid cold, caffeine, and sympathomimetic drugs in all patients.
